News » Author: Mattias Ormestad

Tuuli Lappalainen new director of the SciLifeLab NGI

4th February 2021  -  Categories: Updates

Genetics researcher Tuuli Lappalainen from the New York Genome Center has been appointed as the new director of the National genomics infrastructure (NGI) by SciLifeLab. Tuuli is an experienced researcher with several publications in scientific journals such as Nature and Science. Her research is focused on genetic variation in human populations, where the aim is […]

Spatially resolved transcriptomics elected Method of the Year 2020!

15th January 2021  -  Categories: Updates

NGI proudly offers spatially resolved RNA-seq analyses through the 10X Visium spatial gene expression assay, one of the spatial techniques recently nominated as Method of the Year by Nature Methods. The technology offers positional context of RNA-seq data in microdissected tissues, and has proven to be valuable when studying e.g. disease progression and developmental processes. […]

New NovaSeq v1.5 chemistry

4th December 2020  -  Categories: Updates

NGI is now offering sequencing using Illumina’s v1.5 NovaSeq Chemistry.

Information about sample deliveries during the holidays

5th November 2020  -  Categories: Updates

The last day to submit samples before the holidays is Dec 18th 2020. Please note that you need to have a valid and signed agreement for your project to submit samples. For orders submitted before Dec 14th 2020 we will do our best to prepare a quote in time for you to submit samples before […]

NGI during Covid-19 outbreak

5th November 2020  -  Categories: Updates

In wake of the current health and safety requirements for our staff, we may face occasional delays in processing projects and ask you to bear with us during this time. Some of our key personnel – the people behind the NGI – have been ill or functioning as caregivers for those who are. However, we remain committed to […]

[Closed] NGI is looking for a project coordinator

7th July 2020  -  Categories: Careers

Would you like to work in a dynamic and creative environment in one of the largest sequencing centres in Europe?

NextSeq 2000

1st July 2020  -  Categories: Updates

NGI has recently acquired the latest NextSeq 2000 instrument from Illumina. It is currently being installed at the Stockholm site and will shortly be available for our users.

EASI Genomics is launching an Extraordinary Call for COVID-19 related projects

18th May 2020  -  Categories: Updates

As a part of the EASI Genomics network NGI will provide services for this COVID-19 call. Apply now!

Scroll to top